Clinical Trial Update: Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas [Phase 1]

View source ↗

Summary

Phase 1 study evaluating weekly paclitaxel combined with ramucirumab in patients with advanced gastric adenocarcinoma; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Drugs mentioned

• Cyramza (ramucirumab)
• Taxol (paclitaxel)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Adenocarcinoma | Phase 1 | Status: COMPLETED | Results posted: 2014-06-18